Advertisement

Topics

Latest "The HAMS Harm Reduction Network, Inc" News Stories

00:12 EST 16th December 2017 | BioPortfolio

Here are the most relevant search results for "The HAMS Harm Reduction Network, Inc" found in our extensive news archives from over 250 global news sources.

More Information about The HAMS Harm Reduction Network, Inc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The HAMS Harm Reduction Network, Inc for you to read. Along with our medical data and news we also list The HAMS Harm Reduction Network, Inc Clinical Trials, which are updated daily. BioPortfolio also has a large database of The HAMS Harm Reduction Network, Inc Companies for you to search.

Showing "HAMS Harm Reduction Network" News Articles 1–25 of 5,100+

Friday 15th December 2017

Centene's Washington Subsidiary Reaches agreement with State of Washington

We will continue to work closely with the OIC, including continuing to make refinements and improvements to our network reporting processes. We are committed to address Read more...


Aetna Offers Assistance to Members Affected by Wildfires in Southern California

Aetna (NYSE: AET) is offering resources to members who have been affected by the wildfires in Ventura, Los Angeles, Santa Barbara, and San Diego counties in California. Aetna members can refill their prescriptions early, if needed. Those members who use Aetna’s mail-order pharmacy can either get a prescription at an alternate delivery loc...

Ablation of refractory ventricular tachycardia with a novel, noninvasive radiation technique

1. In this small case series of a novel treatment for ventricular tachycardia, patients receiving stereotactic body radiation therapy (SBRT) guided by noninvasive anatomical and electrocardiographic imaging had near-complete resolution of ventricular tachycardia. 2. There was no evidence of reduction in left ventricular ejection fraction with treatment, and mild inflammatory lung changes seen at t...


Brident Dental Expands Waco Office

Brident Dental & Orthodontics, one of the nation’s leaders in accessible, affordable oral healthcare, today announced it has expanded its dental office in Waco, located at 4215 Franklin Avenue. Brident Dental’s Waco office has doubled in size to accommodate a growing need for orthodontics, general dentistry and specialty dentistry by local...

AngelMD Launches Healthcare Alternative Investment Event: Alpha Conference

Preceding the annual JP Morgan Healthcare event - Alpha Conference in Napa, CA. delivers an alternative investment event focused on early stage healthcare innovation. SEATTLE (PRWEB) December 15, 2017 Healthcare-focused investment platform, AngelMD, announced today a new conference bringing together investors, healthcare, and technology leaders as well as select startups for an invitation-only ev...

Company Profile for Sarah Cannon

Sarah Cannon, the Cancer Institute of HCA Healthcare, offers integrated cancer services with convenient access to cutting-edge therapies for those facing cancer in communities across the United States and United Kingdom. Sarah Cannon’s cancer programs include individualized patient navigation provided by oncology-trained nurses, more than 1,000 blood and...

2018 ASAP Global Alliance Summit to Provide New Business Perspectives and Proven Leadership Practices

Some 50-plus seasoned alliance managers and business insiders to share their know-how and valuable content in the form of sessions, workshops, talks, and panel discussions from 35-plus leading companies, educational institutions, and consultancies CANTON, Mass. (PRWEB) December 15, 2017 The Association of Strategic Alliance Professionals (ASAP), an international association dedicated to the leade...

Connected Horse Concludes 2017 Equine Assisted Workshops and Research with Promising Results for Those Affected by Dementia

Connected Horse, a leader in equine assisted interventions for people affected by dementia, has wrapped up its 2017 Equine Assisted Workshops and research at University of California, Davis with promising results. Rocklin, CA (PRWEB) December 15, 2017 Connected Horse, a leader in equine assisted interventions for people affected by dementia, has wrapped up its 2017 Equine Assisted Workshops and r...

Ozempic® (semaglutide) recommended for approval by the European regulatory authorities

Bagsværd, Denmark, 15 December 2017 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorisation for Ozempic® (semaglutide) for the treatment of adults with type 2 diabetes mellitus. The CHMP recommends Ozempic®, the intended brand name ...

Kettering Health Network Achieves $1 Million in Energy Efficiency Rebates from Dayton Power and Light

Kettering Health Network’s energy efficient initiatives improve the environment The Dayton Power and Light Company (DP&L), a subsidiary of The AES Corporation (NYSE:AES), is recognizing Kettering Health Network today for earning $1 million in rebates through energy-saving measures that are improving the environment. The efforts are part of a broa...

Free Research Reports on These Credit Services Stocks -- Blackhawk Network, Total System ...

www.wallstequities.com/registration Blackhawk Network Holdings Pleasanton, Californiaheadquartered Blackhawk Network Holdings Inc.'s stock finished Thursday's session 0.29% lower at $34.45with a total trading volume of Read more...

Science Surgery: ‘Does having had cancer make you more likely to develop it again?’

Science blog This entry is part 6 of 6 in the series Science Surgery Our Science Surgery series answers your cancer science questions. If you have a question that you’d like us to answer, send it to us using the email address at the bottom of this post. Tommy asked: “Does having had one type of cancer (and cured) make you more susceptible to getting any other type?” To begin answering thi...

Lilly to pump $1.2bn into its biomanufacturing in 2018

Eli Lilly has projected an increased spend across its biomanufacturing network next year to support bulk production and fill/finish of monoclonal antibodies.

B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN achieves clear improvement in revenues and earnings in the 2016/17 financial year

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Final Results 15.12.2017 / 08:30 The issuer is solely responsible for the content of this announcement. BRAIN achieves clear improvement in revenues and earnings in the 2016/17 financial year Revenues increase by 5.8% to EUR 24.1 million Increase of Group total operating performance from EUR 26.1 ...

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN erzielt im Geschäftsjahr 2016/17 klare Umsatz- und Ergebnisverbesserung (deutsch)

B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN erzielt im Geschäftsjahr 2016/17 klare Umsatz- und Ergebnisverbesserung DGAP-News: B.R.A.I.N. Biotechnology Research And Informa...

ABIVAX's ABX464 Phase IIa Data confirm HIV Reservoir Reduction in Oral Presentation at 8th International Workshop on HIV Persistence During Therapy

Peer-reviewed Plenary Presentation ABX464 Reduces HIV Reservoir in Blood in Second Phase IIa Clinical Trial ABIVAX First-Ever to Show Statistically Significant (p New Anti-Inflammatory ABX464 Data...

Thursday 14th December 2017

Stuttering: Stop signals in the brain prevent fluent speech

(Max-Planck-Gesellschaft) A hyperactive network inhibits the flow of speech.

KAIST team develops technology to find optimum drug target for cancer

(The Korea Advanced Institute of Science and Technology (KAIST)) A KAIST research team led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering developed technology to find the optimum drug target according to the type of cancer cell. The team used systems biology to analyze molecular network dynamics that reflect genetic mutations in cancer cells and to predict drug response...

Presbia Announces Board and Management Changes and Financing Proposal to Operate Through to the End of 2018

Presbia PLC (NASDAQ: LENS, or the “Company”), an ophthalmic device company and leader in near-vision restoration, announces that it has re-ordered its operational priorities to focus its resources on FDA approval as well as ongoing clinical and commercial efforts in Germany and South Korea. These actions reduce the Company’s cash burn rate by elimin...

AmerisourceBergen Foundation Launches Municipal Support Program to Help Combat Opioid Abuse

Foundation to distribute drug deactivation resources to communities nationwide to promote the safe disposal of opioids The AmerisourceBergen Foundation today announced the launch of a municipal support program that aims to promote the safe disposal of opioids by providing communities nationwide with resources to deactivate expired or unused prescriptio...

Greenville Memorial Hospital Recognized with Certified Zero Harm Award by Increasing Hand Hygiene Compliance

Greenville Memorial Hospital (GMH) has been awarded a Certified Zero Harm Award from the South Carolina Hospital Association for its prevention of central-line-associated bloodstream infections (CLABSI). The award comes after Greenville Memorial Hospital achieved 12 months with no CLABSIs in its cardiovascular intensive care unit and 24 months with no CLAB...

AtriCure to Present at the 36th Annual JP Morgan Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the 36th

PURE Bioscience Reports Fiscal 2018 Q1 Financial Results

Commercialization Updates on PURE Control® and PURE® Hard Surface Antimicrobial Food Safety Solutions PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, t

Cerveau Technologies, Inc. Signs Research Agreement with KU Leuven University, Belgium

Cerveau Technologies Inc. today announced an agreement with the KU Leuven university in Belgium to support multiple projects over the next several years. These research projects are for studies of an early stage imaging agent (MK-6240) to be used in Positron Emission Tomography (PET) scans for assessing the status and progression of neurofibrillary tangles...

ACPM Announces National Diabetes Prevention Program Grant Winners

The American College of Preventive Medicine (ACPM) has selected six health care organizations to receive grants to develop new practice setting models that address the national type 2 diabetes epidemic. The awardees will develop and test new models to increase prediabetes awareness and screening, testing, and referral of patients with prediabetes to diabet...


Quick Search
Advertisement
 

News Quicklinks